☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AMD patients
Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar- aflibercept) in Korea
March 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.